{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:31:25Z","timestamp":1790238685605,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.drugalcdep.2016.02.035","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T14:43:12Z","timestamp":1457016192000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France"],"prefix":"10.1016","volume":"162","author":[{"given":"Jessica","family":"Delorme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chouki","family":"Chenaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Kabore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Mulliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Tremey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zenut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0005","unstructured":"ANSM, 2013. Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicaments et des produits de sant\u00e9 (ANSM). Outils de surveillance et d\u2019\u00e9valuation\u2013R\u00e9sultats d\u2019enqu\u00eates\u2013ANSM: agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0010","doi-asserted-by":"crossref","first-page":"ES177","DOI":"10.36076\/ppj.2012\/15\/ES177","article-title":"Prevention of opioid abuse in chronic non-cancer pain: an algorithmic, evidence based approach","volume":"15","author":"Atluri","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0015","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.36076\/ppj.2014\/17\/E119","article-title":"Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011","volume":"17","author":"Atluri","year":"2014","journal-title":"Pain Physician"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.285.1.39","article-title":"Deaths attributable to methadone vs buprenorphine in France","volume":"285","author":"Auriacombe","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0025","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4088\/JCP.08m04367","article-title":"Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients","volume":"70","author":"Barry","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/IJGM.S61014","article-title":"The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users","volume":"7","author":"Benyamina","year":"2014","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-013-1614-5","article-title":"Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France","volume":"70","author":"Bezin","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00125-011-2429-5","article-title":"Insulin glargine and risk of cancer: a cohort study in the French national healthcare insurance database","volume":"55","author":"Blin","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00228-011-1077-5","article-title":"Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French national insurance healthcare system","volume":"67","author":"Bongue","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0050","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2014.12.002","article-title":"Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses","volume":"147","author":"Bretteville- Jensen","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0060","first-page":"10","article-title":"Centers for Disease Control and Prevention grand rounds: prescription drug overdoses\u2014a U.S. epidemic","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11596600-000000000-00000","article-title":"Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US","volume":"35","author":"Cepeda","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0091270012436561","article-title":"Opioid shopping behavior: how often, how soon, which drugs, and what payment method","volume":"53","author":"Cepeda","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/AJP.0000000000000067","article-title":"Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse","volume":"30","author":"Cepeda","year":"2014","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpain.2012.10.012","article-title":"Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study","volume":"14","author":"Cepeda","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2014.02.701","article-title":"Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially\u2014insured individuals","volume":"138","author":"Cochran","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2016.02.035_bib0095","first-page":"23","article-title":"Quality of care provided to patients receiving opioid maintenance treatment in Europe: Results from the EQUATOR analysis","volume":"14","author":"Dale-Perera","year":"2012","journal-title":"Heroin Addict. Relat. Clin. Prob."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0100","series-title":"Epidemiology, Causes, and Intervention, International Research Monographs in the Addictions","article-title":"Mortality amongst illicit drug users","author":"Darke","year":"2007"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Med."},{"issue":"Suppl. A","key":"10.1016\/j.drugalcdep.2016.02.035_bib0110","first-page":"A27","article-title":"Follow-up of opioid addicts treated with high-dose buprenorphine in a health care network. National retrospective study. Experience of French general physicians","volume":"151","author":"De Ducla","year":"2000","journal-title":"Ann. M\u00e9d. Interne"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0115","series-title":"Benefits and Risks of Pharmaceutical Opioids: Essential Treatment and Diverted Medication \u2212 a Global Review of Availability, Extra-medical Use, Injection and the Association with HIV","author":"Degenhardt","year":"2008"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addict. Abingdon Engl."},{"issue":"49","key":"10.1016\/j.drugalcdep.2016.02.035_bib0125","article-title":"The impact of chronic pain on opioid addiction treatment: a systematic review protocol","volume":"4","author":"Dennis","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0130","first-page":"363","article-title":"Two years follow-up of a heroin users cohort treated with high dosage buprenorphine Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice subutex)","volume":"48","author":"Duburcq","year":"2000","journal-title":"Rev. D\u00e9pid\u00e9miologie Sant\u00e9 Publique"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2015.10.018","article-title":"Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients","volume":"157","author":"Dunn","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0140","article-title":"Usage patterns of over the counter versus prescription-strength non-steroidal anti-inflammatory drugs in France","author":"Duong","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.euroneuro.2013.09.008","article-title":"Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns\u2014a cohort study","volume":"24","author":"Dupouy","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","article-title":"Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain","volume":"129","author":"Edlund","year":"2007","journal-title":"PAIN"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0160","series-title":"Drug Treatment Overview for France","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0165","series-title":"Public Health Implications","article-title":"Mortality related to drug use in Europe","author":"EMCDDA","year":"2011"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0170","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pain.2006.06.009","article-title":"Critical issues on opioids in chronic non-cancer pain: an epidemiological study","volume":"125","author":"Eriksen","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0180","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1360-0443.2010.03092.x","article-title":"The global diversion of pharmaceutical drugsnon-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures","volume":"105","author":"Fischer","year":"2010","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/pds.3213","article-title":"Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France","volume":"21","author":"Fournier","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1472-8206.2011.00950.x","article-title":"Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey","volume":"26","author":"Frauger","year":"2012","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bcp.12031","article-title":"Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?","volume":"77","author":"Garcia-Portilla","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0205","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of abuse among unintentional pharmaceutical overdose fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874473711104010004","article-title":"Unemployment and substance use: a review of the literature (1990\u20132010)","volume":"4","author":"Henkel","year":"2011","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugpo.2010.10.004","article-title":"The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia","volume":"22","author":"Horyniak","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long- term course of opioid addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0225","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1526-4637.2009.00603.x","article-title":"Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment","volume":"10","author":"Inciardi","year":"2009","journal-title":"Pain Med. Malden Mass"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1526-4637.2006.00255.x","article-title":"Mechanisms of prescription drug diversion among drug-involved club- and street- based populations","volume":"8","author":"Inciardi","year":"2007","journal-title":"Pain Med. Malden Mass"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0235","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/pme.12183","article-title":"The Economic burden of opioid-related poisoning in the United States","volume":"14","author":"Inocencio","year":"2013","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6963-6-46","article-title":"Predictors of opioid misuse in patients with chronic pain: a prospective cohort study","volume":"6","author":"Ives","year":"2006","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0885-3924(99)00144-X","article-title":"Characteristics of methadone maintenance patients with chronic pain","volume":"19","author":"Jamison","year":"2000","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2015.01.013","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients\u2019 attitudes and norms","volume":"54","author":"Johnson","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0260","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2105\/AJPH.2014.301966","article-title":"Determinants of increased opioid-related mortality in the United States and Canada, 1990\u20132013: a systematic review","volume":"104","author":"King","year":"2014","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0265","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.drugpo.2015.03.007","article-title":"Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients","volume":"26","author":"Launonen","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0270","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction","volume":"146","author":"Martell","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.1912","article-title":"Pharmacoepidemiological research using French reimbursement databases: yes we can!","volume":"19","author":"Martin-Latry","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.drugalcdep.2016.02.035_bib0285","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0290","doi-asserted-by":"crossref","first-page":"e69241","DOI":"10.1371\/journal.pone.0069241","article-title":"Estimating the prevalence of opioid diversion by doctor shoppers in the United States","volume":"8","author":"McDonald","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0295","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1001\/jama.2008.793","article-title":"Prescription opioids, overdose deaths, and physician responsibility","volume":"300","author":"McLellan","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0300","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.1717","article-title":"Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study","volume":"18","author":"Noize","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0305","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pds.2263","article-title":"Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey","volume":"21","author":"Nordmann","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1360-0443.2001.96226710.x","article-title":"Injecting misuse of buprenorphine among French drug users","volume":"96","author":"Obadia","year":"2001","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0315","unstructured":"Observatoire Fran\u00e7ais des Drogues et des Toxicomanes (OFDT), 2015. Tableau de bord annuel des traitements de substitution aux opiac\u00e9s [WWW Document]. URL http:\/\/www.ofdt.fr\/statistiques-et-infographie\/tableau-de-bord-annuel-des-traitements-de-substitution-aux-opiaces\/ (accessed 12.9.15)"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0320","series-title":"Les Traitements De Substitution Aux Opiac\u00e9s: Donn\u00e9es R\u00e9centes (No. 94)","author":"Observatoire Fran\u00e7ais des Drogues et des Toxicomanes (OFDT)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0325","first-page":"783","article-title":"Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data","volume":"10","author":"Parente","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2515\/therapie\/2011037","article-title":"Evolution of opioids reimbursement since 2004 from the national database of the General Health Insurance system","volume":"66","author":"Pauly","year":"2011","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2012.03.009","article-title":"Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France","volume":"126","author":"Pauly","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0340","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MLR.0b013e31824ebd81","article-title":"Doctor and pharmacy shopping for controlled substances","volume":"50","author":"Peirce","year":"2012","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0345","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pain.2004.11.011","article-title":"Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain","volume":"113","author":"Peles","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0350","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpsychores.2012.02.009","article-title":"Dynamic risk factors in the misuse of opioid analgesics","volume":"72","author":"Pergolizzi","year":"2012","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0355","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pds.1681","article-title":"Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine","volume":"18","author":"Pradel","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0360","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pds.892","article-title":"Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database","volume":"13","author":"Pradel","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0365","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1526-4637.2012.01450.x","article-title":"A model to identify patients at risk for prescription opioid abuse, dependence, and misuse","volume":"13","author":"Rice","year":"2012","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0370","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2007.02.012","article-title":"Prescription opioid abuse among enrollees into methadone maintenance treatment","volume":"90","author":"Rosenblum","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0375","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.addbeh.2008.07.018","article-title":"Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France","volume":"33","author":"Roux","year":"2008","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0380","first-page":"42","article-title":"Doctor shopping: a phenomenon of many themes","volume":"9","author":"Sansone","year":"2012","journal-title":"Innovations Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0385","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5108","article-title":"Opioids in the UK: what\u2019s the problem?","volume":"347","author":"Stannard","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0390","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11606-015-3212-y","article-title":"Chronic pain and depression among primary care patients treated with buprenorphine","volume":"30","author":"Stein","year":"2015","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0395","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA), 2011. Results from the 2010 National Survey on Drug Use and Health [WWW Document]. URL http:\/\/store.samhsa.gov\/product\/Results-from-the-2010-National-Survey-on-Drug-Use-and-Health-NSDUH-\/SMA11-4658 (accessed 6.3.15)."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0400","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0376-8716(01)00161-2","article-title":"Buprenorphine prescription by general practitioners in a French region","volume":"65","author":"Thirion","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0405","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","article-title":"French national health insurance information system and the permanent beneficiaries sample","volume":"58","author":"Tuppin","year":"2010","journal-title":"Rev. D\u00c9pid\u00e9miologie Sant\u00e9 Publique"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0410","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AJP.0b013e31816b1070","article-title":"Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis","volume":"24","author":"Turk","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0415","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0420","first-page":"897","article-title":"Analytic models to identify patients at risk for prescription opioid abuse","volume":"15","author":"White","year":"2009","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0425","doi-asserted-by":"crossref","first-page":"f5599","DOI":"10.1136\/bmj.f5599","article-title":"Friends, doctors, and tramadol: we might have a problem","volume":"347","author":"Winstock","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0430","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10826080903080664","article-title":"Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia","volume":"45","author":"Winstock","year":"2009","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0435","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v27n01_01","article-title":"The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits","volume":"27","author":"Wisniewski","year":"2008","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0445","series-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.drugalcdep.2016.02.035_bib0450","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jamainternmed.2014.5413","article-title":"Presentation of prescription and nonprescription opioid overdoses to us emergency departments","volume":"174","author":"Yokell","year":"2014","journal-title":"JAMA Intern. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T14:31:37Z","timestamp":1654525897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":90,"alternative-id":["S0376871616001101"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}